PFE - What's Going On With Moderna Stock? | Benzinga
Moderna Inc (NASDAQ: MRNA) shares are continuing to trade lower Tuesday following Pfizer Inc's (NYSE: PFE) warning about reduced Covid-19 product demand.
What Happened: Moderna shares closed Monday down 6.47% at $91.94 after Pfizer slashed its full-year 2023 sales outlook from a range of $67 billion to $70 billion to a new range of $58 billion to $61 billion.
Pfizer noted that the reduced forecast was solely due to waning demand ...